Wegovy® (Semaglutide) is a prescribed injectable treatment intended to be used in conjunction with a balanced diet and regular physical activity, aiming to regulate blood sugar (glucose) levels in adults diagnosed with type 2 diabetes mellitus.
The applicability of Semaglutide in individuals who have previously experienced pancreatitis remains undetermined. It’s important to note that Semaglutide is not intended for those diagnosed with type 1 diabetes. The safety and efficacy of Tirzepatide for those below the age of 18 are still subjects of ongoing investigation.
This medication requires a telemedicine visit every 6 months from our provider. You will be redirected to schedule your telemedicine visit via zoom upon purchasing the plan.